| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 39.02× | 39.02× | 37.65× | 27.42× | 41.56× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.32× | 1.56× | 0.66× | 0.88× | 1.05× | ||
| 0.43× | 0.43× | 0.41× | 0.53× | 0.37× | ||
| 1.97× | 1.97× | 0.31× | 0.36× | 1.44× | ||
| 1.53× | 1.53× | 0.26× | 0.36× | 1.06× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 41.56 | 27.42 | 37.65 | 39.02 | 39.02 | |
| Working Capital Turnover | 1.05 | 0.88 | 0.66 | 1.56 | 1.32 | |
| Asset Turnover | 0.37 | 0.53 | 0.41 | 0.43 | 0.43 | |
| Cash Conversion (CFO/Net Income) | 1.44 | 0.36 | 0.31 | 1.97 | 1.97 | |
| CFO/EBITDA | 1.06 | 0.36 | 0.26 | 1.53 | 1.53 |